409A Board Approval: Turning a Report Into Valid Option Grants

Who Approves the 409A and What That Approval Covers

409A valuation board approval is the governance act that turns a delivered appraisal into option grants that legally exist. Two parties do two different jobs here, and option files fall apart when those jobs get blurred. Your appraiser concludes a per-share fair market value of common stock as of a valuation date. Your board adopts that value as the company’s FMV for compensatory purposes, then authorizes specific grants priced at or above it.

One thing board approval doesn’t do is create the Section 409A safe harbor. Treas. Reg. 1.409A-1(b)(5)(iv)(B)(2) lists the methods that carry a presumption of reasonableness, and “approved by the board of directors” isn’t one of them. The presumption comes from the independent appraisal at (B)(2)(i), which takes its appraiser standard from IRC 401(a)(28)(C). Our 409A safe harbor explainer walks all three methods.

The appraisal buys the presumption. The board buys the grant date.

Authority over option terms is statutory, not housekeeping. For a Delaware corporation, DGCL 157 is the enabling provision. Section 157(a) lets the company create and issue rights or options to acquire its own stock, and 157(b) puts the terms in the board’s hands: options may be issued “in the numbers, at the times and for the consideration as set forth in a resolution of the board of directors.” The exercise price is one of those terms.

Delegation is allowed, with limits the statute names itself. DGCL 157(c) requires the delegating resolution to fix the maximum number of shares, the issuance periods, and the minimum consideration. Then it closes the loop: “No such resolution shall permit a person or body to issue rights or options to such person or body.” A CEO delegation can’t be used to grant the CEO’s own refresh.

Delaware gives the board’s judgment weight too. Under DGCL 152(d), absent actual fraud, “the judgment of the directors as to the value of the consideration … shall be conclusive.” Older practitioner memos cite 157(b) for that language. It sits in 152(d). Real protection under state law, none under the Internal Revenue Code.

So what does the approval actually cover?

• The concluded FMV, adopted from a named report as the company’s fair market value until superseded.
• Each specific award, with grantee, share count, exercise price, ISO or NSO classification, vesting schedule, vesting commencement date, and expiration.
• Plan capacity, confirming the awards fit inside the authorized reserve.
• The form of award agreement in use, plus officer authority to execute and deliver the documents.

The Board Resolution and What It Must Reference

A board resolution that names no valuation report is a resolution an auditor can’t test. The most common defect in a startup option file is a consent reciting that the board “determined the fair market value to be $0.42 per share” with nothing behind it. That’s evidence of a board determination. It isn’t evidence of reliance on a qualified independent appraisal, which is the fact the presumption turns on.

What a board resolution stock option grant must name

1. The valuation report, by title, preparer, and report date. The appraiser’s work is what supports the presumption, so name the firm.
2. The valuation date, which is neither the report delivery date nor the approval date.
3. The concluded per-share fair market value, with the share class stated. Under multiple allocation methods, say which value the board adopts.
4. The period the board adopts it for. Convention is the earlier of the next 409A, a material event, or 12 months after the valuation date.
5. The specific grants, on a Schedule A listing grantee, award type, share count, exercise price, vesting commencement date, and vesting schedule.
6. The plan and the pool. Recite the equity incentive plan and confirm shares remain available in the authorized reserve.

A 409A board consent that approves grants “subject to receipt of the final report” has already moved the grant date. Treas. Reg. 1.421-1(c)(2) gives effect to conditions imposed on the granting of an option “in accordance with the intent of the corporation.” Boards that want a clean grant date approve unconditionally, which means the report has to be final first.

Mechanically you have two routes. DGCL 141(f) authorizes action without a meeting where all board members “consent thereto in writing, or by electronic transmission.” Unanimity isn’t optional, and one unreachable director means no consent and no grant date. The same section allows a forward-effective consent capped at 60 days after the instruction is given, and it requires signed consents to be filed with the minutes “in the same paper or electronic form as the minutes are maintained.”

If any approved award is an incentive stock option, IRC 422(b)(1) through (b)(4) add requirements the file should demonstrate: a stockholder-approved plan, grants inside the 10-year plan window, a term no longer than 10 years, and a price not less than FMV at grant. Stockholders approve the plan, so a board consent can’t cure one they never approved.

Keep straight which of these is law and which is practice. Our essential guide to 409A valuations covers the valuation side of the same spine.

Requirement	Where it comes from
Exercise price at or above FMV on the grant date	Federal tax law, Treas. Reg. 1.409A-1(b)(5)(i)(A)(1)
A resolution setting the number, timing, and consideration of options	Delaware law, DGCL 157(b)
A grant date set by approval under your governance rules, plus mutual understanding of key terms	Accounting standard, ASC 718-10-20 and 718-10-25-5
Reciting the preparer, adopting the FMV in its own resolution, documenting a no-material-event conclusion	Convention, expected by auditors and acquirers

Valuation Date, Approval Date, and Grant Date

Three dates govern an option grant, and they are never interchangeable: the valuation date, the approval date, and the grant date. Each does a different legal job.

Date	What it is	What it governs
Valuation date	The “as of” date of the appraisal	The 12-month clock and the material-information test
Approval date	When the board’s action is final and unconditional	Ordinarily becomes the grant date
Grant date	When the corporate action constituting the offer is complete	The strike price and the share count
Measurement date	The grant date, for equity-classified awards	The fair value that becomes compensation cost
Vesting commencement date	The economic start of vesting credit	Nothing about price. It can precede the grant

The option grant date strike price relationship runs one way. Treas. Reg. 1.409A-1(b)(5)(i)(A)(1) conditions the exemption on an exercise price that “may never be less than the fair market value of the underlying stock … on the date the option is granted,” with the share count fixed on that same original date of grant. Not the offer letter date. Not the start date. Not the day the agreement comes back countersigned.

For statutory options, Treas. Reg. 1.421-1(c)(1) ties the grant date to completion of the corporate action, then hands you a test to draft against. The offer “is not considered complete until the date on which the maximum number of shares that can be purchased under the option and the minimum option price are fixed or determinable.” Read it backward and it’s a drafting instruction. No share count and no price means no grant yet.

Two sub-rules in 1.421-1(c)(2) shape a grant calendar. Stockholder approval of the plan doesn’t push the grant date, because under IRC 424(i) the date is determined as if the option had never been subject to it. An option conditioned on the recipient becoming an employee, though, “is not granted prior to the date the individual becomes such an employee.” Approve a new hire’s grant in advance if you like. It still lands on the start date.

The accounting grant date can lag the approval date

ASC 718-10-20 defines the grant date as “the date at which a grantor and a grantee reach a mutual understanding of the key terms and conditions of a share-based payment award,” and adds that awards requiring individual board approval aren’t granted until all approvals are obtained. ASC 718-10-25-5 supplies the accommodation that makes board approval operative in practice. Mutual understanding is presumed at the date the award is approved “in accordance with the relevant corporate governance requirements” if the award is unilateral and the key terms are expected to be communicated “within a relatively short time period from the date of approval.” Sit on approved grants for six weeks when you normally send them in three days, and the accounting grant date moves, along with the fair value feeding your ASC 718 stock comp expense.

Vesting credit is allowed to look backward. The grant date isn’t. Giving a new hire vesting credit from their start date is routine and legitimate. Dating the grant itself back to that date is a different act entirely. Keep offer letters consistent by stating that equity is subject to board approval and leaving the exercise price out.

Granting Options Between Valuations

So when can you grant options after a 409A? Once the report is final, the board has adopted it unconditionally, and the valuation date sits within 12 months of the grant date. Two independent tests apply at the moment of grant, not at the moment of approval intent.

The first is the 12-month rule at Treas. Reg. 1.409A-1(b)(5)(iv)(B)(2)(i), which requires the appraisal to be as of a date “no more than 12 months before the relevant transaction to which the valuation is applied.” The second sits one subdivision up at (B)(1), which rejects a prior value that “fails to reflect information available after the date of the calculation that may materially affect the value of the corporation.” A grant has to pass both. Our post on 409A refresh triggers covers the material-event list and the cadence argument.

Nothing in the Code requires batching. The pressure comes from governance. Every grant date needs a completed, unconditional board action, and every board action needs a quorum at a meeting or unanimous consent. Grant ad hoc and you produce one consent per hire, with unanimity at risk each time. Batch into a cycle and you produce one consent and one material-event check.

A grant cycle that survives diligence

1. Confirm a currently adopted 409A and compare its valuation date to the planned grant date. If the gap will pass 12 months before the next cycle, start the refresh now.
2. Run the material-event check as of the planned approval date, and document the conclusion even when it’s “no material event.”
3. Pull the grant list from your HR system and reconcile it to approved headcount and offer letters.
4. Check pool availability against the equity ledger, net of outstanding awards and shares already issued on exercise.
5. Classify each award ISO or NSO, and run the IRC 422(d) $100,000 first-exercisable test for every ISO recipient.
6. Draft the consent with the six named references and Schedule A attached.
7. Circulate for unanimous signature. Don’t deliver award agreements before the last signature lands.
8. Record the grants using the approval date as the grant date, file the consent with the minutes, then deliver the agreements promptly so the communication condition holds.

One urgent executive hire between cycles gets a standalone consent, not a grant dated back into the last cycle. Build the cycle backward from your appraiser’s turnaround, which our 409A engagement timeline lays out stage by stage.

Here’s the coordination problem underneath all of it. The grant calendar and the valuation calendar are the same calendar, and most companies run them as two. Indinero works as a year-round finance partner rather than a once-a-year vendor, so the team that knows your valuation date also knows when the 12-month window closes.

Board Minutes and the Documentation Trail

Assume an acquirer’s counsel will reconstruct every grant from source documents, because that is what diligence does. The file that survives has seven components, each traceable to a legal requirement rather than to preference.

• The charter and the authorized share count. DGCL 161 governs the power to issue shares, and exceeding it creates an overissue under DGCL 204(h).
• The plan and its stockholder approval. Required for ISOs under IRC 422(b)(1), within 12 months before or after plan adoption.
• Every pool increase, with board and stockholder action wherever the charter or the plan requires it.
• The signed final 409A report, not a draft. This is the document that supports the presumption.
• The signed consents or minutes adopting the FMV and approving the grants, filed in the form the minutes are kept.
• Executed award agreements and grant notices. They don’t create the grant date, but their absence undercuts the communication condition.
• The equity ledger, tied line by line. Every row needs a consent that authorizes it, and every consent needs rows that match.

That last tie-out isn’t housekeeping, because the ledger feeds a federal filing. IRC 6039 requires a corporation that transfers stock on the exercise of an incentive stock option to file an information return and furnish a written statement to the individual by January 31 of the following year. The vehicle is Form 3921, and Treas. Reg. 1.6039-1(a)(1) enumerates what goes on it: the grant date, the exercise price per share, the exercise date, the fair market value per share on exercise, and the number of shares transferred. Those are the required columns of a defensible cap table, and they land in the same workstream as the rest of your equity compensation payroll.

A grant date that can’t be sourced to a signed consent is a grant date you’re reporting to the IRS on faith. The IRS also maintains an examiner-facing Equity (Stock)-Based Compensation Audit Technique Guide, published as Publication 5992. Treat the option file the way you’d treat anything else headed for audit preparation, because it is.

Where Board Approval Goes Wrong

Board approval fails in a small number of repeatable ways, and each one carries a specific legal consequence rather than a vague risk.

1. Backdated grants. Writing an earlier “as of” date on a consent to catch a lower FMV is the fact pattern the SEC pursued at scale. In September 2006 testimony, Chairman Christopher Cox described abusive backdating as misrepresenting the grant date “to make it appear that the grant was made on an earlier date when the market value was lower,” with more than 100 companies then under investigation.
2. Grants on a stale valuation. Past 12 months from the valuation date, the presumption is unavailable. Inside 12 months but after a material event, (B)(1) says the prior value isn’t reasonable. For an NSO, Section 409A then applies, with income inclusion under IRC 409A(a)(1)(A) plus 20 percent of the includible amount and interest at the underpayment rate plus 1 percentage point under (a)(1)(B). The employee pays that bill, not the company, as our explainer on the IRS rules behind 409A works through.
3. A resolution that names no report. Valid corporate acts under DGCL 152(d), no appraisal in evidence under the Code. State-law validity, no federal presumption.
4. Grants exceeding the authorized pool. A validity problem, not a tax one. DGCL 204(h) reaches shares issued on the exercise of options as putative stock, and the cure is ratification under DGCL 204(a) or validation by the Court of Chancery under DGCL 205(a). Real remedies, real legal bills, usually mid-round.
5. Conditional approvals treated as unconditional. If the consent said “subject to,” the grant date moved. Recording the consent date anyway mis-states the ledger, Form 3921, and the stock comp expense.
6. Promised but never granted equity. An offer letter naming a share count and a price with no board action behind it creates an expectation, and a possible claim, with no grant to match it.
7. Ledger entries that don’t tie to the consents. Duplicate grants, grants recorded at a prior cycle’s strike, grants with no consent at all.

Fixing a mis-priced grant is harder than preventing one. Treas. Reg. 1.409A-1(b)(5)(iv)(B)(3) forecloses the easy route, providing that an established exercise price “may not be changed through the retroactive use of another valuation method.” IRS Notice 2008-113 offers limited correction procedures that can reset the price to grant-date fair market value, generally requiring the written consent of affected holders, completion before exercise, and action within the grantee’s taxable year of grant. ISOs carry a narrow cushion at IRC 422(c)(1) for a good-faith pricing failure. It does nothing for an NSO.

How Indinero Supports the Board on 409A Approvals

Indinero prepares the consent package, runs the material-event check, and reconciles the equity ledger to the signed consents before any grant gets recorded. That’s the work sitting between a delivered report and a defensible grant, and in most companies it has no owner.

One team should hold it because of the chain it runs through. Consent to ledger to Form 3921 to stock comp expense crosses accounting, tax, and reporting, and it holds only if the same people see all four. Bookkeeping, accounting, tax, and fractional CFO bundled under one monthly engagement is the structural reason it holds instead of breaking at a handoff.

What that looks like each cycle:

• Consent preparation with the six named references and a Schedule A built from your actual grant list.
• A documented material-event check, dated to the planned approval date, every cycle.
• Ledger reconciliation against the signed consents before grants are recorded, not after an auditor finds the gap.
• ISO and NSO classification, including the IRC 422(d) $100,000 test and the 83(b) election timing next to it.
• Carrying the approved FMV into the stock comp expense calculation at the correct measurement date.
• Diligence-file assembly, so an acquirer’s counsel can reconstruct every grant from source documents.

Continuous operations since 2009, 500+ regular customers. The valuation itself is one deliverable inside 409A valuation services, and the governance work around it is where grants either hold up or don’t.

Most companies don’t lose the presumption because the appraisal was wrong. They lose it on the paperwork after the appraisal was right.

Frequently asked questions

These are the questions that surface the week before a grant cycle, usually from whoever is drafting the consent. Short answers first, with the regulation or the statute cited wherever the answer turns on it. None of it replaces counsel on a specific grant, but it will tell you which date you’re actually testing.

Does the board have to approve the 409A valuation itself, or only the grants?

The board approves both: it adopts the appraiser’s concluded fair market value as the company’s FMV, then authorizes the specific grants priced against it. Adoption is governance hygiene, not a safe harbor. Treas. Reg. 1.409A-1(b)(5)(iv)(B)(2) lists the methods that carry a presumption of reasonableness, and board approval isn’t one of them. That presumption comes from the qualified independent appraisal at (B)(2)(i). Indinero drafts the consent so it names the report behind the adopted value.

Can the board approve option grants by written consent instead of at a meeting?

Yes, a Delaware board can approve option grants by unanimous written consent under DGCL 141(f), with no meeting required. Unanimity isn’t optional, so one unreachable director means no grant date. A forward-effective consent is capped at 60 days, and signed consents get filed with the minutes. For ASC 718, the grant date still needs approval under your governance requirements plus mutual understanding of key terms. Indinero circulates the consent and holds agreements until the last signature lands.

What happens if the board approved grants before the 409A report was final?

A grant approved subject to receipt of the final 409A report isn’t complete, so the grant date moves to when approval becomes unconditional. Treas. Reg. 1.421-1(c)(1) and (c)(2) control, and a later grant date can push the strike onto a different valuation. You can’t paper it over afterward, because Treas. Reg. 1.409A-1(b)(5)(iv)(B)(3) bars retroactive re-pricing. Indinero reconciles the equity ledger to the signed consents before any grant gets recorded, which is where this usually surfaces.